Stocks / BIIB

BIIB stock forecast

BIOGEN INC · Healthcare · Drug Manufacturers - General

The model's rating

Greatly Outperform

BIIB is rated Greatly Outperform as of November 18, 2026: its medium-term return forecast is in the top fifth of the stocks the model scores.

Changed from Outperform on October 26, 2026.

Premium adds the numeric score behind this label, the medium-term return forecast, and today's full Upfront Picks.

Where this rating comes from: The Upfront Model, whose picks have been recorded with a fingerprint the day they publish since September 18, 2026. See the record.

BIIB is not among the 20 largest holdings published for 2026 Q4. See the portfolio

BIIB against the S&P 500

PeriodBIIBS&P 500 (SPY)
1 month+7.7%-4.7%
3 months+13.5%-4.8%
Year to date+42.9%+7.9%
1 year+48.9%+11.8%

Total return, dividends included.

Key numbers

Price$251.41
Market cap37.16 Billion
P/E (trailing 12 months)106.5
P/S (trailing 12 months)3.6
P/B (latest quarter)1.9
Gross margin74.0%
Net profit margin3.4%
Return on equity1.9%
Beta0.4

As of October 28, 2026.

BIIB and its closest peers

StockCompanyMarket capModel rating
BMY BRISTOL MYERS SQUIBB CO 121.75 Billion Greatly Outperform BMY vs BIIB
PFE PFIZER INC 159.94 Billion Greatly Outperform PFE vs BIIB
GILD GILEAD SCIENCES INC 209.59 Billion Outperform GILD vs BIIB
AMGN AMGEN INC 240.11 Billion Outperform
MRK MERCK & CO INC 339.66 Billion Greatly Outperform
ABBV ABBVIE INC 505.56 Billion Outperform

Questions

What does the Upfront Investment model say about BIIB?

The model rates BIOGEN INC (BIIB) "Greatly Outperform" as of November 18, 2026, which means its medium-term return forecast is in the top fifth of the stocks the model scores. The rating is a statistical forecast, not a recommendation to buy or sell.

How is the BIIB rating produced?

A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.

Is BIIB in the Upfront Investment model portfolio?

BIIB is not among the 20 largest holdings published for 2026 Q4.

The rating is generated by The Upfront Model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.